Low risk human papillomavirus (HPV) DNA test positive from female genital organs
ICD-10 R87.82 is a billable code used to indicate a diagnosis of low risk human papillomavirus (hpv) dna test positive from female genital organs.
The ICD-10 code R87.82 is used to indicate a positive result for a low-risk human papillomavirus (HPV) DNA test derived from female genital organs. Low-risk HPV types, such as HPV 6 and 11, are primarily associated with benign lesions, including genital warts and low-grade squamous intraepithelial lesions (LSIL). While these types are not typically linked to cervical cancer, their presence can indicate the need for monitoring and potential intervention. The positive test result may be asymptomatic, but it can lead to abnormal findings during routine gynecological examinations or Pap smears. Clinicians should assess the patient's history, including previous HPV infections, vaccination status, and any current symptoms, to determine the appropriate follow-up care. The management may involve patient education, regular screenings, and possibly treatment for any associated lesions. Accurate coding is essential for proper patient management and insurance reimbursement.
Detailed patient history, including previous HPV tests and treatments, vaccination status, and any current symptoms.
Routine screenings, follow-up after abnormal Pap results, and management of genital warts.
Ensure that all relevant clinical findings and patient education efforts are documented.
Acute care documentation must include the reason for testing and any immediate symptoms.
Patients presenting with acute symptoms related to genital lesions or warts.
Consider the urgency of treatment and follow-up care in emergency settings.
Used when a patient is tested for HPV as part of routine screening or follow-up.
Document the reason for the test and any relevant clinical findings.
Ensure that the test results are linked to the appropriate diagnosis.
A positive low-risk HPV test indicates the presence of HPV types that are generally associated with benign conditions, such as genital warts, rather than cervical cancer. It is important for patients to understand the implications and follow-up care required.
